Announcement of the Resolution of the 11th Meeting of the 4th Board of Directors
release time:
2025-05-23 10:29
AnnouncementNumber: 2025-009
Stock code: 832316 Securities abbreviation: Tian Zheng Biotech Host brokerage: Shenwan Hongyuan underwriting sponsor
Jilin Tianzheng Biotechnology Co., Ltd
Announcement of the Resolution of the 11th Meeting of the 4th Board of Directors
I. Meeting Convening and Attendance
(1) Meeting convening situation
The meeting will be held on May 21, 2025
2. Meeting format: √ On-site meeting □ Electronic communication meeting
3. Meeting venue: Conference Room on the third floor of the company
4. Time and method for issuing the notice of the board meeting: It will be issued in writing on May 19, 2025
5. Chairperson of the meeting: Mr. CAI Tiyuan, Chairman of the Board
6. Explanation of the legality and compliance of the convening situation:
The convening and holding of this meeting comply with the relevant provisions of the Company Law and other laws, administrative regulations and the Company's Articles of Association.
(II) Attendance at the meeting
Five directors were supposed to attend the meeting, and five directors attended or were authorized to attend.
Ii. Review of the Motion
(1) The proposal on "The Company Providing Guarantee for Bank Loans of Its Wholly-owned Subsidiary" was deliberated and approved
1. Content of the motion:
Hunchun Deren Pharmaceutical Co., LTD., a wholly-owned subsidiary of the company, plans to sign a loan contract with the Hunchun Branch of Industrial and Commercial Bank of China Co., LTD. The estimated loan amount is no more than 1.9 million RMB, with a loan term of one year. Meanwhile, the parent company, Jilin Tianzheng Biotechnology Co., LTD., will provide a guarantee for it (the specific guarantee situation is subject to the signed contract).
2. Abstained from voting:
None.
3. Voting result of the motion: 5 votes in favor; 0 votes against; There were 0 abstentions.
4. Submission of voting results at the shareholders' meeting:
This motion does not need to be submitted to the shareholders' meeting for deliberation.
(2) The proposal on "Jilin Tianzheng Biotechnology Co., LTD. 's intention to conduct Loan Financing" was deliberated and approved
1. Content of the motion:
Due to business requirements, the company intends to sign a RMB loan contract with Jilin Bank Co., LTD. Jilin Sichuan Road Branch. The estimated financing amount is no more than 22 million RMB, and the fund usage period is one year. Jilin Small and Medium-sized Enterprises Financing Guarantee Group Co., Ltd. provides guarantee. Meanwhile, The controlling shareholder and actual controller of the company shall provide joint and several liability guarantee (the specific content shall be subject to the loan and guarantee contract).
2. Abstained from voting:
None.
3. Voting result of the motion: 5 votes in favor; 0 votes against; There were 0 abstentions.
4. Submission of voting results at the shareholders' meeting:
This motion does not need to be submitted to the shareholders' meeting for deliberation.
Iii. Reference Documents
Resolution of the 11th Meeting of the 4th Board of Directors of Jilin Tianzheng Biotechnology Co., LTD.
Jilin Tianzheng Biotechnology Co., LTD
Board of Directors
May 22, 2025
previous page
previous page
Related news
